Desk›Consumer Services› Entero Healthcare Solutions Ltd
Entero Healthcare Solutions Ltd
BSE 544122 · NSE ENTERO · ISIN INE010601016 · Group B · Active
Consumer Discretionary › Consumer Services › Retailing › Pharmacy Retail
₹1,812.30
+3.22%
BSE close, 28 August 2026
₹7,887.69 cr
4.4 cr shares · Small cap
₹2,929.10 cr
as published
337.5× · 4.74×
EPS ₹5.37 · BV ₹382.34
348.24 / 26.88
₹ cr, as filed
25
5 selected · 20%
Reg 30
Sch. III Part A
Price 52-week, BSE
| Against 52-week high | -1.3% |
|---|---|
| Against 52-week low | +92.0% |
| Day change | +3.22% |
| Size band | Small cap |
| Index membership | None |
Valuation as published by BSE
| Earnings per share | ₹5.37 |
|---|---|
| Price / earnings | 337.49× |
| Price / book | 4.74× |
| Book value — derived, price ÷ P/B | ₹382.34 |
| Return on equity | 1.40% |
| Operating margin | 16.16% |
| Net margin | 4.15% |
Consistency check
- P/B ÷ P/E, which must equal ROE
- 1.40%
- ROE as published
- 1.40%
Results ₹ crore, as filed
RevenueNet profit one scale across all three periods, ₹ crore
| Period | Revenue ₹cr | Net profit ₹cr | EPS ₹ | OPM | NPM |
|---|---|---|---|---|---|
| Jun-26 · Q | 83.27 | 3.46 | 0.79 | 16.16% | 4.15% |
| Mar-26 · Q | 78.93 | 13.42 | 3.08 | 22.07% | 17.00% |
| FY25-26 | 348.24 | 26.88 | 6.18 | 13.36% | 7.72% |
Quarter on quarter
- Revenue, quarter on quarter
- +5.5%
- Net profit, quarter on quarter
- -74.2%
- Operating margin, quarter on quarter
- -591 bps
Disclosure profile 25 filings in the window
| Tag | Filings |
|---|---|
| Selected | |
| Board Outcome | 1 |
| Change in Management | 1 |
| Concall Transcript | 1 |
| Investor Presentation | 1 |
| Results | 1 |
| Selected sub-total | 5 |
| Procedural | |
| Analyst / Investor Meet | 4 |
| General | 4 |
| AGM / EGM | 3 |
| Newspaper Publication | 2 |
| SAST | 2 |
| Annual Report | 1 |
| BRSR | 1 |
| Board Meeting | 1 |
| Subsidiary Incorporation | 1 |
| Trading Window | 1 |
| Procedural sub-total | 20 |
| Total | 25 |
Disclosure regime
LODR Reg 30
Read with Schedule III Part A. An equity filer in BSE Group B, so the Regulation 30 disclosure framework and the Schedule III event list both apply.
Filing rhythm · 93 trading days
25 filings · 5 selected · busiest 2026-07-27
Filing rhythm · the twelve most recent
2026-08-072026-09-23
SelectedProcedural
Filings
25 in the window · 11 earlier on record
-
23 September 2026 ·
Closure of Trading Window
Intimation of Closure of Trading Window
Insider Trading / SAST / Closure of Trading Window View filing →
-
22 September 2026 ·
Analyst / Investor Meet - Intimation
Intimation of Schedule of Analyst/Institutional Investor meetings under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015
Company Update / Analyst / Investor Meet View filing →
-
22 September 2026 ·
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Surbhi Singh - Prasid Uno Family Trust
Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →
-
26 August 2026 ·
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Surbhi Singh Prasid Uno Family Trust
Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →
-
24 August 2026 ·
Analyst / Investor Meet - Intimation
Intimation of Schedule of Analyst/Institutional Investor meetings
Company Update / Analyst / Investor Meet View filing →
-
24 August 2026 ·
Change in Management
Completion of tenure of Mr. Rajesh Shashikant Dalal
Company Update / Change in Management View filing →
-
19 August 2026 ·
Shareholder Meeting / Postal Ballot-Scrutinizer's Report
Voting Results along with copy of Scrutinizer's Report
AGM/EGM / AGM View filing →
-
19 August 2026 ·
Shareholder Meeting / Postal Ballot-Outcome of AGM
Proceedings of Annual General Meeting held on Wednesday, August 19, 2026.
AGM/EGM / AGM View filing →
-
17 August 2026 ·
Earnings Call Transcript
Transcript of Earnings Call / Conference Call
Company Update / Earnings Call Transcript View filing →
-
10 August 2026 ·
Analyst / Investor Meet - Outcome
Recording of Earnings Call/ Conference Call on Unaudited Financial Results of the Company for the quarter ended June 30, 2026
Company Update / Analyst / Investor Meet View filing →
-
7 August 2026 ·
Investor Presentation
Investor Presentation on Unaudited Financial Results for the Quarter ended June 30, 2026
Company Update / Investor Presentation View filing →
-
7 August 2026 ·
Unaudited Financial Results For The Quarter Ended June 30, 2026.
Unaudited Financial Results for the Quarter ended June 30, 2026.
Result / Financial Results View filing →
-
7 August 2026 ·
Board Meeting Outcome for Outcome Of Board Meeting Held On August 07, 2026
Outcome of Board Meeting held on August 07, 2026
Board Meeting / Outcome of Board Meeting View filing →
-
5 August 2026 ·
Revised Intimation Of The Earnings Call
Revised intimation of the Earnings Call on the unaudited Financial results of the Company for the quarter ended June 30, 2026
Company Update / General View filing →
-
4 August 2026 ·
Analyst / Investor Meet - Intimation
Intimation of Earnings call on Unaudited Financial Results of the Company for the quarter ended June 30, 2026
Company Update / Analyst / Investor Meet View filing →
-
31 July 2026 ·
Acquisition
Inc orporation of step-down subsidiary, Qurovia Lifesciences Private Limited
Company Update / Acquisition View filing →
-
30 July 2026 ·
Updated Annual Report Of The Company For The Financial Year 2025-26
Updated Annual Report of the Company for the financial year 2025-26
Company Update / General View filing →
-
28 July 2026 ·
Board Meeting Intimation for Unaudited Standalone And Consolidated Financial Results (Along With Limited Review Report) For The Quarter Ended June 30, 2026.
Entero Healthcare Solutions Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2026 ,inter alia, to consider and approve the Unaudited Standalone ....
Board Meeting / Board Meeting View filing →
-
28 July 2026 ·
Newspaper Publication
Newspaper Advertisement - Post dispatch of Notice of the 8th Annual General Meeting through Video Conferencing / Other Audio-Visual Means
Company Update / Newspaper Publication View filing →
-
27 July 2026 ·
Annual Report For The Financial Year 2025-26 Along With The Notice Convening The 8Th Annual General Meeting
Annual Report for the financial year 2025-26 along with the Notice convening the 8th Annual General Meeting
Company Update / General View filing →
-
27 July 2026 ·
Intimation Regarding Dispatch Of Letters To Those Shareholders Whose Email Addresses Are Not Registered With Company/ Registrar And Share Transfer Agent/Depository Participant(S).
Intimation regarding dispatch of letters to those Shareholders whose email addresses are not registered with Company/ Registrar and Share Transfer Agent/Depository Participant(s).
Company Update / General View filing →
-
27 July 2026 ·
Business Responsibility and Sustainability Reporting (BRSR)
Business Responsibility and Sustainability Report for the Financial Year 2025-26
Others / Business Responsibility and Sustainability Reporting (BRSR) View filing →
-
27 July 2026 ·
Reg. 34 (1) Annual Report.
Annual Report for the financial year 2025-26
Others / Reg. 34 (1) Annual Report View filing →
-
27 July 2026 ·
Notice Convening The 8Th Annual General Meeting
The 8th Annual General Meeting of the Members of Entero Healthcare Solutions Limited is scheduled to be held on Wednesday, August 19, 2026, at 12:30 p.m. (IST) through Video Conferencing/Other ....
AGM/EGM / AGM View filing →
-
23 July 2026 ·
Newspaper Publication
News paper advertisement - 8th Annual General Meeting through Video conferencing / Other Audio - Visual Means (VC/OAVM) facility.
Company Update / Newspaper Publication View filing →
RSS feed for Entero Healthcare Solutions Ltd · the 50 most recent filings